secwatch.observer — SEC 8-K summary
======================================

Issuer:     Chemours Co (CC)
CIK:        0001627223
Form:       8-K
Filed at:   2024-03-28T23:59:59+00:00
Accession:  0000950170-24-037412
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Chemours Q4 adjusted EPS $0.31 vs $0.00 YoY; full year net loss $238M on $764M litigation charges
--------------------------------------------------------------------------------

- Q4 2023 net sales $1.4B (+2% YoY); full year net sales $6.0B (-11% YoY).
- Q4 net loss $18M ($0.12 loss/diluted); adjusted net income $46M ($0.31 diluted EPS).
- Full year net loss $238M ($1.60 loss/share); adjusted net income $425M ($2.82 EPS) vs $738M prior.
- Adjusted EBITDA Q4 $176M vs $120M prior; full year $1.0B vs $1.4B, impacted by $89M/$764M litigation charges.
- Segment: TT +7%, TSS +17%, APM -15%; CEO cites destocking and progress on legacy environmental matters.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1627223/000095017024037412/0000950170-24-037412-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1627223/000095017024037412/cc-20240327.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-037412

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer